Induction of apoptosis in a macrophage cell line RAW 264.7 by acemannan, a beta-(1,4)-acetylated mannan

L Ramamoorthy1, I R Tizard

  • 1Department of Veterinary Pathobiology, Texas A & M University, College Station, Texas 77843, USA. l0r7859@nigel.tamu.edu

Insights

Acemannan, an antiviral immunomodulator, triggers apoptosis in macrophages when combined with interferon-gamma (IFNγ). This process involves inhibiting bcl-2 expression, independent of nitric oxide.

Area of Science:

  • Immunology
  • Cell Biology
  • Virology

Background:

  • Acemannan is a beta-(1,4)-linked acetylated mannan with known antiviral properties.
  • It functions as an immunomodulator, activating macrophages in preliminary studies.
  • The interaction between acemannan, interferon-gamma (IFNγ), and macrophage apoptosis requires further elucidation.

Purpose of the Study:

  • To investigate the mechanism by which acemannan induces apoptosis in RAW 264.7 macrophage cells, particularly in the presence of IFNγ.
  • To determine the role of nitric oxide (NO) in acemannan-induced apoptosis.
  • To examine the effect of acemannan and IFNγ on the expression of the anti-apoptotic protein bcl-2.

Main Methods:

  • RAW 264.7 cells were treated with acemannan and IFNγ.
  • Apoptosis was assessed by observing chromatin condensation, DNA fragmentation, and DNA laddering.
  • The effect of nitric oxide inhibition (using N-nitro-L-arginine methyl ester) on apoptosis was evaluated.
  • The expression of bcl-2 protein was analyzed.

Main Results:

  • Acemannan, in combination with IFNγ, induced apoptosis in RAW 264.7 cells, evidenced by characteristic apoptotic morphological and molecular changes.
  • The induction of apoptosis was not mediated by nitric oxide, as NO inhibition did not alter the effect.
  • Acemannan and IFNγ co-treatment led to the inhibition of bcl-2 expression.

Conclusions:

  • Acemannan, alongside IFNγ, effectively induces apoptosis in RAW 264.7 macrophages.
  • The apoptotic pathway activated by acemannan and IFNγ does not rely on nitric oxide signaling.
  • Inhibition of bcl-2 expression is a key component of the mechanism through which acemannan and IFNγ induce apoptosis.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.